0001127602-15-021324.txt : 20150624 0001127602-15-021324.hdr.sgml : 20150624 20150624180459 ACCESSION NUMBER: 0001127602-15-021324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150623 FILED AS OF DATE: 20150624 DATE AS OF CHANGE: 20150624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Shane CENTRAL INDEX KEY: 0001524823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 15950156 MAIL ADDRESS: STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST. CITY: DUBLIN 2 STATE: L2 ZIP: 00000 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-06-23 0001520262 Alkermes plc. ALKS 0001524823 Cooke Shane CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 President, Alkermes plc Ordinary Shares 2015-06-23 4 M 0 18000 14.60 A 58640 D Ordinary Shares 2015-06-23 4 S 0 17100 66.8007 D 41540 D Ordinary Shares 2015-06-23 4 S 0 900 67.5622 D 40640 D Employee Stock Option (Right to Buy) 14.60 2015-06-23 4 M 0 18000 0 D 2021-10-05 Ordinary Shares 18000 142000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.315 to $67.275. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.51 to $67.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 10/5/12. /s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke 2015-06-24